Company · CIK 0001399529
Dicerna Pharmaceuticals Inc
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/ADicerna Pharmaceuticals Inc0001193125-22-039084 · 295.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-367447 · 253.8 KBSEC(opens sec.gov)
- SC 13GDicerna Pharmaceuticals Inc0001193125-21-347158 · 276.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-21-333251 · 718.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001399529-21-000158 · 9.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001399529-21-000157 · 430.3 KBSEC(opens sec.gov)
- 10-QQuarterly update0001399529-21-000142 · 7.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001399529-21-000141 · 439.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001399529-21-000137 · 3.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001399529-21-000095 · 325.5 KBSEC(opens sec.gov)
Insiders
- Aradhye ShreeramEVP & Chief Medical Officer
- Ashburn TheodoreSee Remarks
- Bain Capital Life Sciences Fund, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- Bain Capital Public Equity Management, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BLAIR JAMES C10% Owner
- BROOKSIDE CAPITAL PARTNERS FUND LP10% Owner
- Brookside Capital Trading Fund, L.P.10% Owner
- Brown Bob DChief Scientific Ofr., EVP R&D
Tickers
No tickers on record.
Addresses
business
75 HAYDEN AVENUE
LEXINGTON, MA, 02421
mailing
75 HAYDEN AVENUE
LEXINGTON, MA, 02421
Same industry